InvestorsHub Logo
Followers 3
Posts 13
Boards Moderated 0
Alias Born 10/31/2023

Re: harry crumb post# 5574

Tuesday, 03/26/2024 3:15:19 AM

Tuesday, March 26, 2024 3:15:19 AM

Post# of 5672
There’s the problem about pulling numbers from a chart graph reflecting a pre rev bio during their R&D cash bleed stage.
Because what happens when the R&D stage yields great results and the company decides to bank off these results from selling regional rights, their cash runway all of a sudden overlaps their revenue timeline…
They then transform from a speculative bet to a bio poised to bring in billions of revenue yearly and the SP starts to reflect the pipeline’s fair value.
Here’s why $2.5 is laughable and only someone judging off the chart would predict that.
The risk adjusted Net Present Value of Ocu400 for just US/EU calculated with the most conservative numbers is worth 24x that market cap..
If the MENA region is even a fraction of the value of the US/EU market then this deal alone should be well over that $625m valuation.
Best part about all of it, is that this is just a fraction of Ocugens pipeline lmao.
Love you shorts, you have and will continue to make me a killing. 🍻
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News